Zhuopu Capital

Zhuopu Capital deploys across the full private lifecycle, including seed, start-up, early-stage, growth, expansion/late-stage, and pre-IPO rounds. This multi-stage approach allows the firm to participate in successive financings for portfolio companies, from initial institutional capital through to the final private round before a public listing.

The firm does not publicly disclose sector concentration limits. Its stated mandate is venture generalist, meaning it evaluates opportunities across industries rather than restricting itself to specific verticals like healthcare or enterprise software. This broad aperture is common among Chinese mid-market funds seeking to avoid being locked out of hot deal flow in any single sector.

Unlike pure VC firms that typically exit at Series C or D, Zhuopu Capital explicitly targets pre-IPO rounds alongside early-stage seed and start-up investments. This expansion-stage capability means the firm can hold positions through the full private maturation of a company, including the capital-intensive growth rounds that precede a Shanghai or Hong Kong listing.

The firm's capital structure is not publicly disclosed. Chinese private equity firms operating under the 'Asset Manager' classification commonly manage commingled funds raised from institutional limited partners, though some also invest significant general partner commitments. Specific details on Zhuopu Capital's fund vehicles and LP base are not available in the public record.

Based in Beijing, Zhuopu Capital focuses on China's domestic private market. While the firm has not published explicit geographic restrictions, its operational headquarters and the nature of its strategy — targeting companies that may seek China domestic IPOs — suggest a focus on mainland China-based enterprises.